BrenX H1 2026: Net Loss Narrows 18% but Going Concern Doubt Persists
BRNX is trading near its 52-week low of $2.062 (14% above the low) on elevated volume (2.2× avg).
Summary
BrenX's H1 2026 results show narrowing losses but zero revenue, a going concern warning, and heavy reliance on dilutive Alpha Capital financing with conversion prices down to $3.12.
Key Events · Earnings and Guidance · BRNX
-
Going Concern Doubt Disclosed
Management states 'substantial doubt about the Company's ability to continue as a going concern within one year' due to accumulated deficit, history of losses, and negative operating cash flows.
-
Revenue Collapses to Zero
H1 2026 revenue was $0 versus $387K in H1 2025, as no project milestone satisfied revenue recognition criteria while Tempo and Wolfson projects remained under construction.
-
Alpha Capital Financing Terms Deteriorate
Conversion prices on Alpha preferred shares fell from $76.23 (Feb 2026) to $3.12 (Aug 2026) due to anti-dilution ratchet provisions, with warrants exercisable at $87.36 per share.
-
EIB Waiver Through September 15
European Investment Bank waived a $1.72M payment due July 28, 2026 through September 15, 2026, while the company negotiates a potential full settlement of the credit facility.
Analysis · BRNX · Manufacturing
BrenX reported H1 2026 results with net loss down 18% to $6.09M and operating loss down 9% to $5.97M, but revenue fell to zero. The filing discloses substantial doubt about the company's ability to continue as a going concern within one year, with only $5.69M in cash against $8.88M in total liabilities. The company is relying on continued Alpha Capital fundings (conversion prices collapsing from $76.23 to $3.12 per share) and an EIB waiver through September 15, 2026 to stay afloat. Three reverse stock splits in 2026 (7:1, 5:1, 6:1) have compressed the share count to maintain Nasdaq listing compliance.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1753 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRNX was trading at $2.36 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $2.06 to $512.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.